Dyck, P J <br/><br/>
Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans.  [electronic resource] 

 -  Neurology  Feb 1997 
 - 501-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.48.2.501  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Female<br/>Hot Temperature<br/>Humans<br/>Male<br/>Middle Aged<br/>Nerve Growth Factors--adverse effects<br/>Pain--chemically induced<br/>Pain Threshold--drug effects<br/>Peripheral Nervous System Diseases--drug therapy<br/>Sensation Disorders--chemically induced<br/>Sensory Thresholds--drug effects